Search Results - "Pagel, Michael A."

Refine Results
  1. 1

    Using Acetaminophen's Toxicity Mechanism to Enhance Cisplatin Efficacy in Hepatocarcinoma and Hepatoblastoma Cell Lines by Neuwelt, Alexander J., Wu, Y. Jeffrey, Knap, Narcyz, Losin, Marcin, Neuwelt, Edward A., Pagel, Michael A., Warmann, Steven, Fuchs, Joerg, Czauderna, Piotr, Wozniak, Michal

    Published in Neoplasia (New York, N.Y.) (01-10-2009)
    “…Background/Aims: Acetaminophen overdose causes hepatotoxicity mediated by toxic metabolites generated through the cytochrome P450 enzyme. The objective of this…”
    Get full text
    Journal Article
  2. 2

    Blood–brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses by Burks, Scott R., Kersch, Cymon N., Witko, Jaclyn A., Pagel, Michael A., Sundby, Maggie, Muldoon, Leslie L., Neuwelt, Edward A., Frank, Joseph A.

    “…Intracarotid arterial hyperosmolar mannitol (ICAHM) blood–brain barrier disruption (BBBD) is effective and safe for delivery of therapeutics for central…”
    Get full text
    Journal Article
  3. 3

    Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model by Neuwelt, Edward A, Pagel, Michael A, Kraemer, Dale F, Peterson, Darryl R, Muldoon, Leslie L

    “…Thiol chemoprotective agents can reduce chemotherapy side effects, but clinical use is limited due to concerns of impaired chemotherapeutic efficacy. We…”
    Get more information
    Journal Article
  4. 4

    High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats by Wu, Yingjen Jeffrey, Pagel, Michael A, Muldoon, Leslie L, Fu, Rongwei, Neuwelt, Edward A

    Published in Anticancer research (01-08-2017)
    “…Brain metastases commonly occur in patients with malignant skin, lung and breast cancers resulting in high morbidity and poor prognosis. Integrins containing…”
    Get full text
    Journal Article
  5. 5

    N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models by Muldoon, Leslie L., Wu, Y. Jeffrey, Pagel, Michael A., Neuwelt, Edward A.

    Published in Journal of neuro-oncology (01-02-2015)
    “…Decreasing oxidative damage with the antioxidant agent N-acetylcysteine (NAC) can block the side effects of chemotherapy, but may diminish anti-tumor efficacy…”
    Get full text
    Journal Article
  6. 6

    Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity by Muldoon, Leslie L., Pagel, Michael A., Netto, Joao Prola, Neuwelt, Edward A.

    Published in Journal of neuro-oncology (01-02-2016)
    “…We tested the hypothesis that intra-arterial (IA) infusion of temozolomide into the internal carotid artery would safely improve drug delivery to brain and…”
    Get full text
    Journal Article
  7. 7

    Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis by Pishko, Gregory L, Muldoon, Leslie L, Pagel, Michael A, Schwartz, Daniel L, Neuwelt, Edward A

    Published in Fluids and barriers of the CNS (17-02-2015)
    “…Blockade of vascular endothelial growth factor (VEGF) to promote vascular normalization and inhibit angiogenesis has been proposed for the treatment of brain…”
    Get full text
    Journal Article
  8. 8

    Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma by MULDOON, Leslie L, LEWIN, Seth J, DOSA, Edit, KRAEMER, Dale F, PAGEL, Michael A, DOOLITTLE, Nancy D, NEUWELT, Edward A

    Published in Clinical cancer research (15-04-2011)
    “…To evaluate the effect of rituximab monoclonal antibody (mAb) on MRI tumor volumetrics and efficacy in a rat model of central nervous system (CNS) lymphoma…”
    Get full text
    Journal Article
  9. 9

    Delayed Administration of Sodium Thiosulfate in Animal Models Reduces Platinum Ototoxicity without Reduction of Antitumor Activity by MULDOON, L. L, PAGEL, M. A, KROLL, R. A, BRUMMETT, R. E, DOOLITTLE, N. D, ZUHOWSKI, E. G, EGORIN, M. J, NEUWELT, E. A

    Published in Clinical cancer research (01-01-2000)
    “…Platinum-based chemotherapeutic agents, such as carboplatin and cisplatin, are effective against many human tumors, but their use may be limited by a high…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    A Physiological Barrier Distal to the Anatomic Blood-Brain Barrier in a Model of Transvascular Delivery by Muldoon, Leslie L, Pagel, Michael A, Kroll, Robert A, Roman-Goldstein, Simon, Jones, Russell S, Neuwelt, Edward A

    Published in American journal of neuroradiology : AJNR (01-02-1999)
    “…Osmotic disruption of the blood-brain barrier (BBB) provides a method for transvascular delivery of therapeutic agents to the brain. The apparent global…”
    Get full text
    Journal Article
  13. 13

    Delivery of Herpesvirus and Adenovirus to Nude Rat Intracerebral Tumors After Osmotic Blood-Brain Barrier Disruption by Nilaver, Gajanan, Muldoon, Leslie L., Kroll, Robert A., Pagel, Michael A., Breakefield, Xandra O., Davidson, Beverly L., Neuwelt, Edward A.

    “…The delivery of viral vectors to the brain for treatment of intracerebral tumors is most commonly accomplished by stereotaxic inoculation directly into the…”
    Get full text
    Journal Article
  14. 14

    In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity by Neuwelt, E A, Brummett, R E, Remsen, L G, Kroll, R A, Pagel, M A, McCormick, C I, Guitjens, S, Muldoon, L L

    Published in Cancer research (Chicago, Ill.) (15-02-1996)
    “…When carboplatin (cis-diammine-1,1-cyclobutane-dicarboxylato-platinum) delivery to brain tumors is optimized with osmotic blood-brain barrier disruption…”
    Get full text
    Journal Article
  15. 15

    Abstract 4477: Safety and efficacy of intracarotid administration of temozolomide in a rat model of intracerebral metastasis by Muldoon, Leslie L., Pagel, Michael A., Neuwelt, Edward A.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Purpose: Temozolomide (Temodar; Merck) is an alkylating chemotherapeutic agent used to treat glioblastoma and other brain malignancies. After oral…”
    Get full text
    Journal Article
  16. 16

    Abstract 839: N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models by Muldoon, Leslie L., Wu, Y. Jeffrey, Pagel, Michael A., Beeson, Kathleen A., Neuwelt, Edward A.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract PURPOSE. Cisplatin chemotherapy is used in the treatment of many pediatric cancers, but has significant toxicities that impact patient quality of…”
    Get full text
    Journal Article
  17. 17

    Abstract 5529: Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma by Muldoon, Leslie L., Lewin, Seth J., Dosa, Edit, Pagel, Michael A., Doolittle, Nancy D., Neuwelt, Edward A.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Purpose: To evaluate monoclonal antibody (mAb) delivery, tumor volumetrics on magnetic resonance imaging (MRI), and efficacy in a rat model of central…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The Influence of Anesthetic Choice, PaCO2, and Other Factors on Osmotic Blood-Brain Barrier Disruption in Rats with Brain Tumor Xenografts by Remsen, Laura G., Pagel, Michael A., McCormick, Christopher I., Fiamengo, Steven A., Sexton, Gary, Neuwelt, Edward A.

    Published in Anesthesia and analgesia (01-03-1999)
    “…Increasing the delivery of therapeutic drugs to the brain improves outcome for patients with brain tumors.Osmotic opening of the blood-brain barrier (BBB) can…”
    Get full text
    Journal Article
  20. 20

    Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers by Kroll, R A, Pagel, M A, Muldoon, L L, Roman-Goldstein, S, Fiamengo, S A, Neuwelt, E A

    Published in Neurosurgery (01-10-1998)
    “…To compare transient blood-brain barrier disruption (BBBD) by hypertonic mannitol with pharmacological modification of the blood-tumor barrier by the…”
    Get full text
    Journal Article